Jump to:
loading...| Preferred Name |
Ibrutinib |
|
| Synonyms |
|
|
| ID |
http://www.phoc.org.cn/pmo/class/PMO_00026234 |
|
| Database_Cross_Reference |
MSH:C551803 USPMG:MTHU002508 SNOMEDCT_US:715598009 NCI_FDA:1X70OSD4VX MTHSPL:1X70OSD4VX RXNORM:1442981 NDFRT:N0000189502 DRUGBANK:DB09053 MMSL:d08170 NDDF:015287 MMSL:29840 MEDCIN:343942 NCI:C81934 VANDF:4032872 ATC:L01XE27 SNOMEDCT_US:710228002 |
|
| label |
Ibrutinib |
|
| MCID |
MC00913326 |
|
| PMOID |
PMO:00026234 |
|
| prefixIRI |
pmo:PMO_00026234 |
|
| prefLabel |
Ibrutinib |
|
| Synonym |
1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one ibrutinib IBRUTINIB ibrutinib (medication) Ibrutinib (substance) chemotherapeutics growth-signaling inhibitors ibrutinib Ibrutinib (product) 2-Propen-1-one, 1-((3R)-3-(4-amino-3-(4-phenoxyphenyl)-1h-pyrazolo(3,4-d)pyrimidin-1-yl)-1-piperidinyl)- |
|
| Tree Number |
T6.4.4.1.2.27.6 |
|
| subClassOf |
Create mapping